|
CN104045640A
|
|
Preparation method for high purity L-calcium levofolinate
|
|
CN104027326A
|
|
Ambroxol hydrochloride atomization inhalant, and preparation method and application thereof
|
|
CN103172640A
|
|
Preparation method of (R)-N-bromine-methyl naltrexone and naltrexone derivatives
|
|
CN103772292A
|
|
Ambrisentan-DMSO co-crystal, preparation method and application thereof
|
|
CN103446070A
|
|
Roflumilast solid quick-release preparation and preparation method thereof
|
|
CN103183672A
|
|
Novel moxifloxacin hydrochloride crystal, and preparation method and application thereof
|
|
CN103183671A
|
|
Novel moxifloxacin hydrochloride crystal, and preparation method and application thereof
|
|
CN103185757A
|
|
Detection method of moxifloxacin (R, R) isomer and application thereof
|
|
CN103172629A
|
|
Synthesis method of high-purity moxifloxacin hydrochloride
|
|
CN103169675A
|
|
Moxifloxacin hydrochloride preparation and preparation method thereof
|
|
CN103169701A
|
|
Telmisartan amlodipine double-layer tablet and preparation method thereof
|
|
CN103012255A
|
|
Roflumilast crystal form compound, preparation method, composition and applications thereof
|
|
CN102641211A
|
|
Method for preserving ambroxol solution
|
|
CN102558190A
|
|
(R)-N-brooethyl naltrexone crystal form compound and preparation method, combination and application thereof
|
|
CN102485709A
|
|
Preparation method of vitamin K2 compound
|
|
CN102464689A
|
|
Preparation method of intermediate compound for synthesizing adenosine
|
|
CN102101862A
|
|
Method for preparing L-sodium folinate or DL-sodium folinate
|
|
CN102101858A
|
|
Preparation method of ramosetron derivatives and applications thereof
|
|
CN101647771A
|
|
Silybin dihemisuccinate disodium oral preparation and preparation method thereof
|
